Conservative versus proactive care after EUS-guided gallbladder drainage for acute cholecystitis
Official title: Conservative Versus Proactive Management of Acute Cholecystitis After EUS-guided Transmural Gallbladder Drainage. Multicenter Randomized Clinical Trial: FUGITIVE Trial (FUGITIVE)
Run by Hospital General Universitario de Alicante · NCT06967597 · Data updated 2026-11-12
This trial will test whether, for people with acute cholecystitis who cannot have surgery, keeping the endoscopic gallbladder stent in place long-term or doing regular endoscopic cleanings and removing the stent works better.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 82 (estimated) |
| Sponsor | Hospital General Universitario de Alicante Academic / other |
| Locations | 2 sites (Alicante, Alicante and 1 other locations) |
| Status | Recruiting |
| Started | June 1, 2025 |
| Main results expected | June 1, 2026 |
| Study ends | June 1, 2027 |
| Registry record updated | June 10, 2025 |
| Trial ID | NCT06967597 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults (≥18) with confirmed acute cholecystitis per Tokyo 2018 who are unfit for cholecystectomy (for example age ≥80, ASA ≥III, high comorbidity burden, or low functional status) and who have received EUS-GBD with a LAMS are ideal candidates.
✕Probably not a fit
Patients who are suitable candidates for standard cholecystectomy, those with altered gastrointestinal anatomy preventing endoscopic access, severe coagulopathy, very short life expectancy, or inability to tolerate sedation are unlikely to receive benefit from this protocol.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This randomized interventional study enrolls adults with acute cholecystitis who are unfit for surgery and have undergone EUS-guided transmural gallbladder drainage with a lumen-apposing metal stent (LAMS). Participants are assigned to conservative management with indefinite retention of the LAMS or to a proactive strategy involving scheduled endoscopic cholecystoscopy, gallstone removal, and stent revision or removal. Outcomes include recurrent cholecystitis, procedure-related complications, need for additional drainage or surgery, and stent-related adverse events over planned follow-up. The trial procedures are performed at a single center by experienced endoscopists using standard endoscopic techniques.
Why it matters
Potential benefit: If successful, the results could identify the safer, more effective follow-up approach to prevent recurrent gallbladder infections and reduce stent-related complications in patients who cannot have surgery.
How similar studies have gone: Previous studies suggest EUS-guided gallbladder drainage can have fewer complications than percutaneous drainage, but evidence is limited and conflicting about the best long-term management of LAMS.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patient ≥ 18 years of age * Confirmed acute cholecystitis diagnosed according to Tokyo 2018 criteria. * Patient unfit for surgery: if meets one or more of the following criteria: age ≥ 80 years, American Society of Anesthesiology (ASA) ≥ III, Charlson Comorbidity Index \> 5 and/or Karnofsky \< 50, or patient unwilling to undergo surgery. * Gallbladder drainage by LAMS stent. * Informed Consent signed Exclusion Criteria: * Patient refusal to participate in the study * Gastrointestinal surgically modified anatomy preventing endoscopic access to the gallbladder. * Technical failure to perform endoscopic ultrasound guided-gallbladder drainage. * Moderate or severe ascites. * Severe coagulopathy International Normalized Ratio \>1.5 and/or fibrinogen \<120) or thrombocytopenia (platelets \<20,000). * Patient unable to tolerate sedation or general anesthesia * Haemodynamically unstable patient * Life expectancy \<6 months * Baseline ECOG ≥4 * Patient with ongoing malignancy * Pregnancy * Acute pancreatitis
Where it's running
-
Hospital General Universitario Dr. Balmis
Alicante, Alicante, Spain Recruiting -
Hospital Universitario Dr Balmis Alicante
Alicante, Alicante, Spain Not yet recruiting
Study contacts
- Study coordinator: José Ramón Aparicio Tormo, MD
- Email: japariciot@gmail.com
- Phone: (0034)965933468
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Percutaneous vs. Endoscopic Gallbladder Drainage for those who aren’t surgery candidates
This randomized trial tests two less-invasive gallbladder drainage methods to see which works better for people with acute gallbladder infection who aren’t candidates for surgery.
-
Cholecystitis: EUS-guided Gallbladder Drainage vs Cyst removal by LCC in older adults
In people aged 75 and up with acute cholecystitis, this study tests whether an endoscopic drainage procedure (EUS-GBD) works as well as the standard gallbladder removal surgery (LCC).
-
Deep learning rapid MRI for preoperative evaluation of acute cholecystitis.
This will test whether a new fast abdominal MRI using deep learning can provide image quality comparable to standard MRI for adults with acute cholecystitis who need preoperative scans.
-
Early versus delayed gallbladder removal after tube drainage for moderate or severe acute cholecystitis.
This trial tests whether removing the gallbladder soon after a drainage tube is placed or waiting several weeks leads to fewer complications for adults with moderate or severe acute cholecystitis.
-
One-year outcomes after different treatments for acute cholecystitis in people aged 70 and older
This project will compare supportive care, drainage, and surgery for people 70 and older with acute cholecystitis to see which approach leads to better health and fewer repeat treatments after one year.
-
Preventing acute cholecystitis using endoscopic techniques
This study is testing if a new endoscopic technique can help prevent acute cholecystitis in patients with certain conditions better than standard care.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.